Alere announced a voluntary Class 1 recall of the Alere INRatio2 PT/INR Professional Test Strips due to significantly different test results between the Alere INRatio2 PT/INR Professional Test Strips ...
Similar number of out-of-range next INR values for patients with, without extended testing interval (HealthDay News) — For stable warfarin-treated patients, extended international normalized ratio ...
New Orleans, LA - Results of a new randomized comparison shows that weekly home INR monitoring is safe but did not reduce stroke, major bleeds, or death when compared with monthly clinic-based INR ...
Please provide your email address to receive an email when new articles are posted on . The onset of the COVID-19 pandemic forced health care systems to adapt clinical practice to limit patient ...
October 21, 2010 (Loma Linda, California) — As compared with monthly high-quality clinic testing, weekly self-testing of INR levels did not significantly delay the time to a first stroke, major ...
Concerned over nine serious adverse events, three of which described bleeding associated with patient deaths, Alere Inc. of Waltham, MA issued a voluntary urgent recall of its PN 99008G2 INRatio2 ...
The US Food and Drug Administration (FDA) has concluded that inaccurate results from the point-of-care device used to measure international normalized ratio (INR) values in warfarin-treated patients ...
According to estimates, the global INR test metres industry will be valued US$ 1,268.3 million in 2022 and US$ 1,336.2 million in 2023. According to Future Market Insights forecasts, the market for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback